These Numbers Could Change Investor Views For Precision Biosciences Inc (NASDAQ: DTIL)
Currently, there are 7.48M common shares owned by the public and among those 3.73M shares have been available to trade. The company’s stock has a 5-day price change of 21.54% and -36.81% over the past three months. DTIL shares are trading 49.61% year to date (YTD), with the 12-month market performance down to -56.64% lower. […]
Precision Biosciences Inc (NASDAQ: DTIL) Is Getting Increasingly Hard To Ignore
Acadian Asset Management LLC recently announced the acquisition of new stake in Precision Biosciences Inc (NASDAQ:DTIL). The institutional investor has increased its shareholding in the Healthcare company by 8.34% to 3.15 million shares with purchase of 0.24 million shares. This fresh investment now brings its stake to 2.60% valued currently at $1.12 million. In addition, […]
